Sorrel Wolowacz

Fracture liaison services for the evaluation and management of patients with osteoporotic fracture: a cost-effectiveness evaluation based on data collected over 8 years of service provision

A. R. McLellan, Sorrel Wolowacz, Evelina A. Zimovetz et al. · Osteoporosis International · 2011 · 251 citations

Skeletal Trauma, Health Economics, Health Policy +11

Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty

Neil Roskell, Jonathan Plumb, Joseph A. Caprini et al. · Thrombosis and Haemostasis · 2008 · 181 citations

Thrombosis, Venous Thrombosis, Dabigatran Etexilate +12

Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report

Sorrel Wolowacz, Andrew Briggs, Vasily Belozeroff et al. · Value in Health · 2016 · 158 citations · Full text

Healthcare Value, Health Economics, Health Policy +12

Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery

Sorrel Wolowacz, Neil S. Roskell, Fiona Maciver et al. · Clinical Therapeutics · 2009 · 79 citations

Thrombosis, Venous Thrombosis, Dabigatran Etexilate +9

Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS)

Stefan Andreas, C. Chouaïd, Sarah Danson et al. · Lung Cancer · 2018 · 67 citations · Full text